Rating Change
BTIG reiterated its Buy rating on Perspective Therapeutics, Inc. (AMEX:CATX) on October 07, 2026.
reiterateAMEX:CATX
BTIG Reiterates Buy Rating on Perspective Therapeutics, Inc. (CATX)
BTIG reiterated its Buy rating on Perspective Therapeutics, Inc. (AMEX:CATX) on October 07, 2026.
At publication ·
What changed
Perspective Therapeutics, Inc. (AMEX:CATX) · reiterate
- Firm
- BTIG
- Rating
- Buy to Buy
- Price at event
- $2.46
- Market capitalization
- $200.3M
At a glance
Key takeaways
- BTIG reiterated a Buy rating on Perspective Therapeutics (CATX) on October 7, 2026, with the stock trading at $2.46 and a market cap of $200.3M.
Market Context
Perspective Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $2.46 with a market capitalization of $200.3M. The stock has declined 51.4% over the past 52 weeks.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Perspective Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Perspective Therapeutics, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | BTIG | Buy | N/A |
| Sep 18, 2026 | William Blair | Outperform | N/A |
| Sep 15, 2026 | Wedbush | Outperform | N/A |
| Aug 19, 2026 | BMO Capital | Outperform | N/A |
| Aug 14, 2026 | B of A Securities | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View CATX Stock Page
Frequently Asked Questions
What does the Buy rating mean for CATX?
A rating of Buy from BTIG reflects the analyst's outlook on Perspective Therapeutics, Inc. (AMEX:CATX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CATX forecast page.